We’re proud to share a recent interview with Adam Rusin, Board Member at BrainScan, where he offers exclusive insights into the technology, vision, and clinical value behind our AI-driven diagnostic solution.
In the interview, Adam discusses how BrainScan is redefining brain pathology diagnostics through the application of advanced deep learning algorithms and seamless integration into real-world hospital workflows. The platform is already supporting over 40 hospitals in Poland, enabling physicians to detect intracranial hemorrhages, brain tumors, and stroke symptoms faster and more accurately than ever before.
“Our goal is simple but powerful-make diagnostic support with AI available at scale, without disrupting the clinical process. We’re augmenting radiologists, not replacing them,” says Adam Rusin.
The conversation also explores how BrainScan ensures regulatory compliance, data security, and scalability, allowing its platform to grow across international markets. Adam shares stories from the field, including real clinical cases where BrainScan’s AI helped save critical minutes—and lives.
What sets BrainScan apart is its balance between cutting-edge AI innovation and clinical usability. Developed in collaboration with practicing radiologists and neurologists, the solution is designed to fit into existing PACS and RIS systems, while continuously learning and adapting to local clinical standards.
Read the full interview to discover:
- How BrainScan uses AI to detect neurological emergencies in real time
- Why hospitals are choosing BrainScan as their trusted AI partner
- What’s next for BrainScan on the global stage of healthcare innovation
We believe that AI in radiology is no longer a future trend—it’s a present necessity. And we’re proud to be leading this transformation.
